Buprenorphine transdermal skin patch and Cangrelor Intravenous
Determining the interaction of Buprenorphine transdermal skin patch and Cangrelor Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: cangrelor
Brand name: Kengreal
Synonyms: Cangrelor
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine transdermal skin patch-Cangrelor tetrasodium
- Buprenorphine transdermal skin patch-Cannabidiol
- Buprenorphine transdermal skin patch-Cantil
- Buprenorphine transdermal skin patch-Capacet
- Buprenorphine transdermal skin patch-Capastat
- Buprenorphine transdermal skin patch-Capastat Sulfate
- Cangrelor Intravenous-Buprenorphine, Buprenorphine Hydrochloride
- Cangrelor Intravenous-Buprenorphine/naloxone Oromucosal, Sublingual
- Cangrelor Intravenous-Buproban
- Cangrelor Intravenous-Bupropion
- Cangrelor Intravenous-Bupropion and naltrexone
- Cangrelor Intravenous-Bupropion Extended-Release Tablets